Publication Cover
Neurocase
Behavior, Cognition and Neuroscience
Volume 14, 2008 - Issue 4
290
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Effect of propranolol on verbal problem solving in autism spectrum disorder

, , , &
Pages 378-383 | Received 12 Mar 2008, Accepted 24 Jul 2008, Published online: 15 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rachel M. Zamzow, Bradley J. Ferguson, Alexandra S. Ragsdale, Morgan L. Lewis & David Q. Beversdorf. (2017) Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers. Journal of Clinical and Experimental Neuropsychology 39:6, pages 596-606.
Read now
Rachel M. Zamzow, Shawn E. Christ, Sanjida S. Saklayen, Amanda J. Moffitt, Kimberly E. Bodner, Katherine F. Higgins & David Q. Beversdorf. (2014) Effect of propranolol on facial scanning in autism spectrum disorder: A preliminary investigation. Journal of Clinical and Experimental Neuropsychology 36:4, pages 431-445.
Read now
Ananth Narayanan, Catherine A. White, Sanjida S. Saklayen, Amir Abduljalil, Petra Schmalbrock, Tom H. Pepper, Brad N. Lander & David Q. Beversdorf. (2012) Functional connectivity during language processing in acute cocaine withdrawal: A pilot study. Neurocase 18:6, pages 441-449.
Read now

Articles from other publishers (22)

Mohammed Al-Beltagi. (2023) Pre-autism: What a paediatrician should know about early diagnosis of autism‎. World Journal of Clinical Pediatrics 12:5, pages 273-294.
Crossref
Nihit Gupta & Mayank Gupta. (2023) Off-label psychopharmacological interventions for autism spectrum disorders: strategic pathways for clinicians. CNS Spectrums, pages 1-16.
Crossref
Carla Carnovale, Cristiana Perrotta, Sara Baldelli, Dario Cattaneo, Cristina Montrasio, Silvia S Barbieri, Giulio Pompilio, Chiara Vantaggiato, Emilio Clementi & Marco Pozzi. (2023) Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovascular Research 119:3, pages 647-667.
Crossref
Damian Koevoet, P. K. H. Deschamps & J. L. Kenemans. (2023) Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder. Frontiers in Neuroscience 16.
Crossref
Łukasz Szeleszczuk & Dawid Frączkowski. (2022) Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder. International Journal of Molecular Sciences 23:17, pages 10099.
Crossref
Shoumitro Deb, Meera Roy, Bharati Limbu & Marco Bertelli. 2022. Handbook of Autism and Pervasive Developmental Disorder. Handbook of Autism and Pervasive Developmental Disorder 1157 1172 .
David Q. Beversdorf. (2020) The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment. Seminars in Pediatric Neurology 35, pages 100834.
Crossref
John P HegartyIIII, Rachel M Zamzow, Bradley J Ferguson, Shawn E Christ, Eric C Porges, Jeffrey D Johnson & David Q Beversdorf. (2019) Beta -adrenergic antagonism alters functional connectivity during associative processing in a preliminary study of individuals with and without autism . Autism 24:3, pages 795-801.
Crossref
Eric B. London, J. Helen Yoo, Eric D. Fethke & Barbie Zimmerman-Bier. (2020) The Safety and Effectiveness of High-Dose Propranolol as a Treatment for Challenging Behaviors in Individuals With Autism Spectrum Disorders. Journal of Clinical Psychopharmacology 40:2, pages 122-129.
Crossref
Neetu Nair, John P. HegartyIIII, Bradley J. Ferguson, Patrick M. Hecht, Michael Tilley, Shawn E. Christ & David Q. Beversdorf. (2020) Effects of stress on functional connectivity during problem solving. NeuroImage 208, pages 116407.
Crossref
María Andrea Castillo, Kendy Eduardo Urdaneta, Neomar Semprún-Hernández, Anna Lisa Brigida, Nicola Antonucci, Stephen Schultz & Dario Siniscalco. (2019) Speech-Stimulating Substances in Autism Spectrum Disorders. Behavioral Sciences 9:6, pages 60.
Crossref
Eric B. London. (2018) Neuromodulation and a Reconceptualization of Autism Spectrum Disorders: Using the Locus Coeruleus Functioning as an Exemplar. Frontiers in Neurology 9.
Crossref
Ilyas Sagar-Ouriaghli, Kate Lievesley & Paramala J Santosh. (2018) Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders. Journal of Psychopharmacology 32:6, pages 641-653.
Crossref
John P. HegartyIIII, Bradley J. Ferguson, Rachel M. Zamzow, Landon J. Rohowetz, Jeffrey D. Johnson, Shawn E. Christ & David Q. Beversdorf. (2016) Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder. Brain Imaging and Behavior 11:5, pages 1278-1289.
Crossref
Rachel M. Zamzow, Bradley J. Ferguson, Janine P. Stichter, Eric C. Porges, Alexandra S. Ragsdale, Morgan L. Lewis & David Q. Beversdorf. (2016) Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study. Psychopharmacology 233:7, pages 1171-1178.
Crossref
Traolach S. Brugha, Lucy Doos, Althea Tempier, Stewart Einfeld & Patricia Howlin. (2015) Outcome measures in intervention trials for adults with autism spectrum disorders; a systematic review of assessments of core autism features and associated emotional and behavioural problems. International Journal of Methods in Psychiatric Research 24:2, pages 99-115.
Crossref
Patrick M. Hecht, Matthew J. Will, Todd R. Schachtman, Lauren M. Welby & David Q. Beversdorf. (2014) Beta-adrenergic antagonist effects on a novel cognitive flexibility task in rodents. Behavioural Brain Research 260, pages 148-154.
Crossref
Christa J. Anderson, John Colombo & Kathryn E. Unruh. (2012) Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder. Developmental Psychobiology 55:5, pages 465-482.
Crossref
Kimberly E. Bodner, David Q. Beversdorf, Sanjida S. Saklayen & Shawn E. Christ. (2012) Noradrenergic Moderation of Working Memory Impairments in Adults with Autism Spectrum Disorder. Journal of the International Neuropsychological Society 18:03, pages 556-564.
Crossref
Ananth Narayanan, Catherine A. White, Sanjida Saklayen, Mary J. Scaduto, Allen L. Carpenter, Amir Abduljalil, Petra Schmalbrock & David Q. Beversdorf. (2010) Effect of Propranolol on Functional Connectivity in Autism Spectrum Disorder—A Pilot Study. Brain Imaging and Behavior 4:2, pages 189-197.
Crossref
David Q. Beversdorf. 2010. The Neurochemical Basis of Autism. The Neurochemical Basis of Autism 175 184 .
John R. Hughes. (2009) Update on autism: A review of 1300 reports published in 2008. Epilepsy & Behavior 16:4, pages 569-589.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.